Premier Biomedical (BIEI) Stock Statistics & Valuation Metrics

Premier Biomedical has a market cap or net worth of $974.99K. The enterprise value is $1.85M.

Premier Biomedical has 1,299,981,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Premier Biomedical’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 8.94%.

The current PE Ratio of Premier Biomedical is ―. Premier Biomedical’s PEG ratio is 0.00.

In the last 12 months, Premier Biomedical had revenue of 0.00 and earned -202.00K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -19.50K and capital expenditures 0.00, giving a free cash flow of -19.50K billion.

Premier Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Premier Biomedical upcoming earnings date is ―, ―.

Premier Biomedical as a current ratio of <0.01, with Debt / Equity ratio of -28.63%

In the past 12 months, Premier Biomedical has paid 0.00 in taxes.

Premier Biomedical EV to EBITDA ratio is -500.20, with an EV/FCF ratio of -9.08.

Premier Biomedical has $400.00 in cash and marketable securities with $720.19K in debt, giving a net cash position of -$719.79K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Premier Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―